Pfizer (PF) terminated its acquisition agreement with Allergan Plc (AGN)
The new set of rules released by the U.S. Treasury Department to make it difficult for U.S. companies to conduct tax inversions contributed Pfizer’s decision. Analysts noted that the new regulations seem almost directly aimed at Pfizer-Allergan. In one of two major parts of the new rules, the U.S. government would not consider the assets acquired by these companies that occurred in the last three years.
Pfizer Value Exists Indoors
Pfizer announced it decided to rely on enhancing the value of . . .